In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp
- PMID: 11751145
- PMCID: PMC127002
- DOI: 10.1128/AAC.46.1.245-247.2002
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp
Abstract
We investigated the in vitro interaction of caspofungin and amphotericin B for clinical isolates of Aspergillus and FUSARIUM: Synergy tests were performed using the checkerboard method and following the NCCLS M38-P guidelines in Antibiotic Medium 3 broth supplemented to 2% glucose. Antagonism was not observed for any of the isolates tested. Caspofungin and amphotericin B were synergistic or synergistic to additive for at least half of the isolates.
Similar articles
-
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.Antimicrob Agents Chemother. 2005 Aug;49(8):3572-4. doi: 10.1128/AAC.49.8.3572-3574.2005. Antimicrob Agents Chemother. 2005. PMID: 16048988 Free PMC article.
-
In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.Antimicrob Agents Chemother. 2003 Apr;47(4):1416-8. doi: 10.1128/AAC.47.4.1416-1418.2003. Antimicrob Agents Chemother. 2003. PMID: 12654681 Free PMC article.
-
Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.J Antimicrob Chemother. 2006 Dec;58(6):1168-76. doi: 10.1093/jac/dkl392. Epub 2006 Oct 27. J Antimicrob Chemother. 2006. PMID: 17071635
-
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.Rev Iberoam Micol. 2003 Dec;20(4):121-36. Rev Iberoam Micol. 2003. PMID: 15456349 Review.
-
Caspofungin: the first representative of a new antifungal class.J Antimicrob Chemother. 2003 Mar;51(3):513-21. doi: 10.1093/jac/dkg117. J Antimicrob Chemother. 2003. PMID: 12615851 Review.
Cited by
-
Fusarium Osteomyelitis in a Patient With Pearson Syndrome: Case Report and Review of the Literature.Open Forum Infect Dis. 2016 Oct 7;3(4):ofw183. doi: 10.1093/ofid/ofw183. eCollection 2016 Oct. Open Forum Infect Dis. 2016. PMID: 27757410 Free PMC article.
-
Central nervous system Aspergillus fumigatus infection after near drowning.J Clin Pathol. 2004 Feb;57(2):202-4. doi: 10.1136/jcp.2003.010066. J Clin Pathol. 2004. PMID: 14747452 Free PMC article.
-
Disseminated Fusariosis in a Patient With Acute Myeloid Leukemia: A Case Report.Cureus. 2019 Oct 16;11(10):e5922. doi: 10.7759/cureus.5922. Cureus. 2019. PMID: 31788380 Free PMC article.
-
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.Antimicrob Agents Chemother. 2007 Jun;51(6):2053-64. doi: 10.1128/AAC.00873-06. Epub 2007 Mar 26. Antimicrob Agents Chemother. 2007. PMID: 17387150 Free PMC article.
-
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients.BMC Infect Dis. 2007 Apr 18;7:28. doi: 10.1186/1471-2334-7-28. BMC Infect Dis. 2007. PMID: 17442100 Free PMC article.
References
-
- Abruzzo, G. K., C. J. Gill, A. M. Flattery, L. Kong, J. G. Smith, V. B. Pikounis, K. Bartizal, and H. Rosen. 2000. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice. Antimicrob. Agents Chemother. 44:2310–2318. - PMC - PubMed
-
- Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, V. B. Bikounis, J. M. Balkovec, A. F. Bouffard, J. F. Dropinski, H. Rosen, H. Kropp, and K. Bartizal. 1997. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 41:2333–2338. - PMC - PubMed
-
- Arthington-Skaggs, B. A., D. W. Warnock, and C. J. Morrison.2000. Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrob. Agents Chemother. 44:2081–2085. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous